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Abstract 
Previously different types of nucleosides with a six membered carbohydrate moiety have been 
evaluated for their potential antiviral and antibiotic properties and as building blocks in nucleic 
acid synthesis. However, a pyranose nucleoside with a 1,4-substitution pattern like 1-2,4-
dideoxy-4-C-hydroxymethyl--L-lyxopyranosylthymine (4) has not been studied yet. Modelling 
suggested that this nucleoside would show the 4C1 conformation in contrast to anhydrohexitol 
nucleosides (1) whose most stable conformation is 1C4. The key to the synthesis of 4 involves the 
stereoselective introduction of the hydroxymethyl group onto the C-4 carbon of the pyranose 
sugar. Attempts to achieve this via hydroboration/oxidation of a C-4'-exocyclic vinylic 
intermediate selectively yielded the undesired -directed hydroxymethyl group. Therefore, we 
envisaged another approach in which the C-4 substituent was introduced upon treatment of  2,3-
O-isopropylidene-1-O-methyl-4-O-phenoxythiocarbonyl--L-lyxopyranose with -
tributylstannyl styrene. This allowed stereoselective -directed introduction of a 2-phenylethenyl 
group at C-4, which was converted via oxidation/reduction (OsO4, NaIO4/ NaBH4) into the 
desired 4-hydroxymethyl group (20). The resulting 1-O-methyl-2,3,6-tri-O-acetyl protected sugar 
was coupled with silylated thymine, using SnCl2 as Lewis acid (22). After suitable protection, 
Barton deoxygenation of the 2'-hydroxyl function of the obtained ribo-nucleoside yielded the 
desired 2'-deoxynucleoside 4, indeed showing the expected equatorial orientation of the thymine 
ring (4C1). 
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Introduction 
Nucleosides with a six membered carbohydrate moiety have been evaluated for their potential 
antiviral1,2,3,4 and antibiotic5 properties and as building blocks in nucleic acid synthesis.6,7 
Antiviral activity1,2,3 has been found in the hexitol series (1) (Figure 1). These molecules are 
characterized by the presence of an axial base moiety in the most stable conformation.1 When 
evaluated as ligand for HSV-1 TK, it was observed that the hexitol nucleoside cocrystallizes with 
the enzyme in a conformation with an equatorial base moiety (which is a high energy 
conformation).3 This conformation, however, is the most stable one for the carbocyclic congener 
(2).4 When incorporated in oligonucleotides, it is suggested that the carbocyclic nucleoside 
undergoes a chair flip and that it adopts the same conformation as found in HNA.8 These 
observations clearly show the possibility of conformational adaptation of 1,4-substituted (when 
considering the base moiety and the hydroxymethyl substituent) nucleosides dependent on their 
'biological' environment. 
-Pyranose nucleosides (3) have a base moiety in the 1'-position and an hydroxymethyl group in 
the 5'-position.9 Both substituents are equatorially oriented. This conformation is very stable, no 
chair flip has been observed and oligonucleotides built up out of the pyranose nucleosides show 
only a very small helical twist.10 No biological activity has been determined for this type of 
natural-like nucleosides. A pyranose nucleoside with a 1,4-substitution pattern (4) has not been 
studied yet, due to its difficult synthetic availability. Sugar-base condensation reaction of its 
appropriate 2'-deoxy sugar precursor is expected to give rise to the thermodynamically most 
stable -nucleoside.11 Therefore the  synthetic scheme should involve the introduction of the base 
moiety using anchimeric assistance of a 2'-acetoxy group in order to be able to isolate the -
nucleoside. Pyranose nucleoside 4 is a structural analogue of an anhydrohexitol nucleoside (1) as 
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crystallised with the active site of HSV-1 TK and an anlogue of a carbocyclic nucleoside (2) in its 
most stable conformation, which motivates the synthesis and biological evaluation of this new 
type of six-membered nucleoside analogue.  
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Figure 1: structures of compounds 1-5. 
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Results and Discussion  
Chemistry  
Two strategies towards the synthesis of 5, the ribo-precursor of the target nucleoside, were 
already attempted.12 Both reaction schemes are not useful for the synthesis of significant amounts 
of the target molecule due to low yields and very difficult separation problems at different stages. 
In one of these attempts Doboszewski and Herdewijn12 experienced that treatment of 4-deoxy-
2,3-O-isopropylidene-1-O-methyl-4-C-methylene--D-erythro-pentopyranose (6) with borane in 
THF, followed by oxidation with H2O2 yielded mainly the undesired 4--hydroxymethyl sugar, 
probably caused by sterical hindrance of the 2,3-O-isopropylidene protective group during borane 
addition.  
In other studies, we observed that preferential attack of borane on an exo double bond is not 
always predictable and may be governed by complexation of the reagent and steric effects.13 By 
carrying out the hydroboration/oxidation of the 4-methylene function after sugar-base coupling, 
we postulated that the presence of the thymine moiety would favor a 4C1 conformation of the 
pyranose, which reduces the steric hindrance caused by the isopropylidene protective group 
(Figure 2). We hoped this would influence the stereochemical outcome of this reaction towards 
the formation of the 4--hydroxymethyl compound (5).  
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Figure 2: Image of the sterical hindrance caused by the 2',3'-O-isopropylidene in the 1C4 
and 4C1 conformation. 
 
Synthesis was started from 4-deoxy-2,3-O-isopropylidene-1-O-methyl-4-C-methylene--D-
erythro-pentopyranose (6), obtained in 4 steps from L-lyxose (Scheme 1).12 
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aReagents: (a) CF3COOH, H2O; (b) (Ac)2O, pyridine; (c) 5-methyl-2,4-
bis(trimethylsilyl)oxypyrimidine, CH3CN, SnCl2; (d) NH3, MeOH; (e) 2,2-dimethoxypropane, 
acetone, p-toluenesulphonic acid; (f) (i) 9-BBN-H, THF, (ii) H2O2, NaOH; (g) (PhO)2CO, 
NaHCO3, DMF; (h) HOAc, H2O. 
  
Because acid catalysed exchange of the 1-O-methylgroup of 6 with an 1-O-acetylgroup is known 
to cause partial ring opening,12 it was decided to maintain the methyl protective group at the 1-O-
position. The 2,3-O-isopropylidene protective group of 6 was selectively removed upon short 
treatment with CF3COOH12 and the 2- and 3-hydroxyl groups were reprotected by acetylation. 
Coupling of the resulting sugar 8 with silylated thymine in the presence of trimethylsilyl triflate 
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or SnCl4 as catalysts proceeded slowly and yielded an uncharacterized side product with a similar 
polarity as 9, rendering purification of the desired nucleoside difficult. This problem could be 
overcome by performing the coupling reaction under reflux conditions in CH3CN using SnCl2 as 
a Lewis acid, which selectively yielded the desired 1--nucleoside  in 48% yield.14 The 
remaining starting material 8, could be recuperated (37 %). To avoid possible side reactions 
during hydroboration,15 the 2'- and 3'-hydroxyl groups were deprotected and reprotected with an 
isopropylidene protective group to yield 11. Reaction of 11 with 9-BBN-H exclusively yielded 
12, the undesired epimer. The selectivity of the formation of 12 was most unexpected. Analysis 
of its 1H-NMR spectrum reveals an axial-axial coupling between H-1' and H-2' and another one 
between H-4' and H-5'. The former is indicative for an equatorial orientation of the thymine ring, 
while the latter and the narrow H-3' signal (half band width of 7.8 Hz), suggest a 4C1 chair 
conformation with an -directed 4'-hydroxymethyl. This assumption was supported by a 
NOEDIF experiment, showing a weak increase (0.53 %) of the H-2' signal upon irradiation of the 
H-4' signal. After deprotection of 12 with acetic acid (to give 13), the -orientation of the 4'-
CH2OH was confirmed via protection of the 6'- and 3'-hydroxyls with an isopropylidene 
protective group (14), which would be formed less likely for 5. Apparently, sterical hindrance of 
the 2',3'-O-isopropylidene and the formation of the thermodynamically most stable product (both 
the 4'-hydroxymethyl and the base are oriented equatorially)11 govern the stereochemical 
outcome of the hydroboration. Attempts to increase the sterical hindrance at the -side of the 
sugar ring, through the formation of a 2,2'-anhydronucleoside (15) failed. Upon treatment of 10 
with diphenylcarbonate and NaHCO3, elimination of the base occurred, yielding an 
uncharacterised highly volatile sugar analogue.  
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Because synthesis of 4 from 10 failed, it was decided to exploit the steric space at the -side of 
the sugar ring through radical-mediated introduction of a carbon group (Scheme 2).  
Scheme 2.a Synthesis of 4 
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aReagents: (a) PhOC(S)Cl, DMAP, CH3CN; (b) -tributylstannyl styrene, AIBN, benzene; (c) 
NMMO, OsO4, dioxane; (d) NaIO4, H2O; (e) NaBH4, EtOH, H2O; (f) CF3COOH, H2O; (g) 
(Ac)2O, pyridine; (h) 5-methyl-2,4-bis(trimethylsilyl)oxypyrimidine, CH3CN, SnCl2; (i) NH3, 
MeOH; (j) (iPr2SiCl)2O, DMF; (k) PhOC(S)Cl, DMAP, CH3CN; (l) Bu3SnH, AIBN, toluene; (m) 
Bu4NF, THF. 
Thus 2,3-O-isopropylidene-1-O-methyl-4-O-phenoxythiocarbonyl--L-lyxopyranose (17), 
obtained through reaction of 16 with phenyl chlorothionocarbonate,16 was reacted with -
tributylstannylstyrene.17 This led to stereoselective introduction of a 2-phenylethenyl group at the 
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-side of the sugar ring (18) as indicated by its 1C4 conformation and the positive NOEDIF effect 
between H-3' and H- of the styrene moiety (3.9 % enhancement).18  Via oxidative cleavage of 
the double bond and in situ reduction (OsO4, NaIO4/ NaBH4), the phenylethenyl group of 18 was 
converted into a 4-hydroxymethyl group in a 53% overall yield (20).18 A similar reaction 
sequence as described for the synthesis of 10, was employed for the conversion of 20 to ribo-
analogue 5. The yield of the sugar-base condensation reaction was only 38%. The presence of the 
acetoxymethyl moiety in the 4'-position (instead of the 5'-position in natural sugars) has an 
important effect on the reaction. The 4'-acetoxymethyl group would favor -attack of the base 
moiety,11 while the neighbouring group effect of the 2'-acetoxygroup would favor -attack of the 
thymine base.11 To allow selective deoxygenation of the 2'-hydroxyl of 5, we envisaged a 
simultaneous protection of the 3'- and 6'-hydroxyl groups as 1,1,3,3-tetraisopropyldisiloxan-1,3-
diyl (TIPDS). At room temperature this reaction was unsuccessful due to the axial position of the 
4'-hydroxylmethyl- and 3'-hydroxyl functions. Heating to 30°C allowed conformational change 
of the sugar moiety in order to adopt the 1C4 conformation, positioning both groups equatorially 
and resulting in a successful protection.19 Esterification of the 2'-hydroxyl as a phenyl 
thionocarbonate ester, followed by Barton deoxygenation and removal of the TIPDS group with 
TBAF, yielded the desired six-membered ring nucleoside 4. Upon removal of the TIPDS-
protective group, the chair conformation of the sugar ring was restored to the 4C1 conformation 
(J1',2' = 11.4 Hz), indicating that the thymine ring of 4 indeed adopts an equatorial orientation.  
 
Conformational analysis 
The conformations of nucleosides 4, 5, 13, 23 and 25 were studied by NMR spectroscopy. The 
data are given for each compound in the experimental section.  A standard numbering system is 
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used for carbon atoms as exemplified for 4 in Figure 3. All 13C resonances were consistently 
assigned by gHMQC experiments. The 1H-NMR results for 4, 5, 13, 23 and 25  are summarized 
in Table 1. Due to occasional overlapping of 1H-NMR spectra, full spectral analysis was difficult 
in the case of 5 and 13. Coupling constants in the pentopyranosyl parts of 4 and 5 are essentially 
the same; hence the conformational analysis for compound 4 applies to compound 5 as well. This 
is also the case for the 23-25 couple.  
Table 1.a 1H NMR Chemical shifts () and Coupling Constants (J) in sugar parts of  4, 5, 13, 
23 and 25. 
  13 5 23 25 4 
proton coupling  J  J  J  J  J 
1'  5.60  5.59  5.36  5.93  5.82  
 1'2'A  9.6  9.6  2.7  4.8  11.4 
 1'2'B        0  0 
2'A  3.63  3.66  4.49  2.18  1.51  
 2'A2'B        14.7  11.4 
 2'A3'  3.6  b  2.7  10.4  b 
 2'A2'OH  b  b  5.1     
2'B        2.54  1.96  
 2'B3'        3.3  <1 
3'  3.95  3.97  3.99  4.26  4.02  
 3'4'  b  b  10.2  10.4  b 
 3'3'OH  b  b      2.7 
4'  1.91  1.77  2.22  1.79  1.51  
 4'5'A  11.7  0  11.4  11.7  0 
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 4'5'B  4.8  2.4  5.7  4.8  2.1 
 4'6'A  b  b  0  0  7.2 
 4'6'B  6.3  b  2.1  2.7  8.4 
5'A  3.52  3.66  3.75  3.72  3.77  
 5'A5'B  11.7  11.7  11.4  11.7  11.4 
5'B  3.68  3.83  3.87  3.86  3.92  
6'A  under H2O  3.50  3.55  3.57  3.50  
 6'A6'B  10.8  11.7  11.1  11.7  10.1 
 6'A6'OH  b  b      5.1 
6'B  3.41  3.59  3.92  4.14  3.60  
 6'B6'OH  b  b      5.1 
a Chemical shifts indicated in the first column are -values relative to the residual solvent peak in 
DMSO-d6 (2.48 ppm) in the case of 4, 5, 13 and 23 and in CDCl3 (7.26 ppm) in the case of 25. 
Coupling constants between the protons indicated in the second column are values in Hz. Protons 
are labeled by the number of the carbon atom to which they are bonded; if two protons are 
bonded to the same carbon atom, the one resonating at a higher field is denoted by A and the 
other by B.  
b Not determined.  
 
According to the Karplus equation, the coupling between H-1' and H-2' (J1',2' = 9.6 Hz) in 
compound 13 indicates, that the dihedral angle between these protons is close to 180°C, 
consistent with an axial-axial arrangement of these bonds in a chair conformation. This points to 
an equatorially oriented base. The J4',5'A (11.7 Hz) and the small coupling for H-3' indicate that H-
4' and H-5'A are in axial and H-3' in an equatorial arrangement and thus lead to the chair 
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conformation as shown in Figure 3. Herein the 4'-hydroxymethyl is necessarily directed 
equatorially. 
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Figure 3. Structure of 4 and 13. 
In 4, proton H-1' shows also a large coupling (11.4 Hz) with H-2'A, indicating an axial position 
of both protons. The 3' proton is in an equatorial conformation because its half band width (½) 
is about 7.2 Hz for three couplings. This cannot contain an axial-axial coupling. Also the absence 
of a large coupling between H-4'-H-5'A or H-4'-H-5'B points to an equatorial H-4' proton and 
further proves that 4 is in a chair conformation with the base in an equatorial position and the 4'-
hydroxymethyl axially oriented as depicted in Figure 3.  
In 23, a J1',2'-value of 2.7 Hz indicates an equatorial orientation of both protons and thus an 
axially directed thymine ring. From J3',4' (10.2 Hz) and J4',5'A (11.4 Hz) it can be concluded that 
H3', H4' and H5'A are all three in an axial orientation, hereby confirming the flipping of the chair 
conformation from 4C1 to 1C4 upon introduction of a TIPDS protective group on 5 (Figure 4). 
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Figure 4. Structure of 23. 
Summarising, the values of the vicinal H,H-coupling constants lead to the conclusion that 13, 4 
and 5 are in chair conformations with the base in an equatorial position, contrary to 23 and 25 
where the base is in an axial orientation.  
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The data for 4 and 5 indicate that the conformational preference of 4-deoxy-4-C-hydroxymethyl-
-L-lyxo-pyranosyl nucleosides is opposite to that of the anhydro-hexitol nucleosides (Figure 1).1 
When 4 is considered, an axially oriented heterocycle would lead to an unfavorable 1,3-diaxial 
interaction between the nucleoside base and the 3'- and 5'-postions. With an equatorially oriented 
heterocycle, this unfavorable interaction is present between the 4'-hydroxymethyl function and 
the hydrogen atom in the 2'-positon and also between the 3'-OH and the H-5' and H-1'. These 
latter interactions may be less unfavorable than the ones with the thymine ring. Considering the 
anhydro-hexitol nucleosides, on the contrary, only one sterically unfavorable 1,3-diaxial 
interaction is present when the nucleoside base is oriented axially. Apart from this, a hydrogen 
bond between the 6'-CH2OH and the ring oxygen may also stabilise the 4C1 conformation in 4 
and 5. 
Conclusions 
We have successfully developed a stereoselective approach for the synthesis of 1-2,4-dideoxy-4-
C-hydroxymethyl--L-lyxopyranosylthymine (4) from 2,3-O-isopropylidene-1-O-methyl--L-
lyxopyranose (16) in 13 steps. The key steps of this synthesis route involve the stereoselective 
introduction of the 6'-carbon on the -side of the sugar ring, via radical mediated substitution of 
the 4'-hydroxyl group by a phenylethenyl group (17  18) followed by the introduction of the 
base via a SnCl2-mediated coupling. Conformational analysis proves that 4 shows the expected 
4C1 conformation with an equatorially oriented thymine ring. Biological evaluation of this 
nucleoside will be published elsewhere.
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Experimental Section 
See the Supporting Information for general synthetic methods and materials. 
2,3-Di-O-acetyl-4-deoxy-1-O-methyl-4-methylene--D-erythro-pentopyranose (8)  
Compound 612 (1.02 g, 5.08 mmol) was treated with 90 % trifluoroacetic acid (9 mL) during 5 
min. After evaporation, water was added, followed by Dowex 1x2 (OH- form) to neutralize 
residual acid. The resin was removed by filtration and washed with water. The combined water 
filtrates were evaporated and the residue was thoroughly dried under high vacuum. The resulting 
4-deoxy-1-O-methyl-4-methylene--D-erythro-pentopyranose (7) was dissolved in pyridine. 
Ac2O was added and the mixture was stirred at room temperature for 2h. Evaporation and 
coevaporation with toluene yielded crude 8 (980 mg, 79 %).  1H-NMR (300 MHz, CDCl3):  2.10 
(6H, s, OCOCH3), 3.43 (3H, s, OCH3), 4.09 (1H, d, J = 12.3 Hz, H-5A), 4.34 (1H, ddd, J = 12.3, 
1.5 and 0.6 Hz, H-5B), 4.72 (1H, d, J = 2.4 Hz, H-1), 5.02 and 5.10 (2H, 2m, methylene), 5.14 
(1H, m, H-2), 5.78 (1H, m, H-3); 13C NMR (75 MHz, CDCl3):  20.1 (OCOCH3), 21.0 
(OCOCH3), 55.6 (OCH3), 64.2 (C-5), 68.8 (C-3), 70.7 (C-2), 100.0 (C-1), 110.6 (C-6), 138.2 (C-
4), 169.8 (CO), 170.4 (CO); HRMS (ESI-MS) for C11H16O6 M+Na+: found, 267.0849; calcd, 
267.0844. 
1-[2,3-Di-O-acetyl-4-deoxy-4-methylene--D-erythro-pentopyranosyl]thymine (9) 
Thymine (991 mg, 7.86 mmol) was suspended in hexamethyldisilazane (87.8 mL, 416 mmol), 
containing trimethylsilylchloride (0.71 mL, 5.6 mmol) and pyridine (7 mL). The mixture was 
heated to 125° C and stirred overnight. The reaction mixture was evaporated and co-evaporated 
with toluene. The resulting residue and 8 (980 mg, 4.01 mmol) were dissolved in CH3CN (27 
mL), SnCl2 (anhydrous, 1.98 g, 10.5 mmol) was added and the mixture was refluxed under 
nitrogen during 39 h. After cooling, the mixture was poured in 10 % Na2CO3 and extracted with 
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CH2Cl2. After drying and evaporation of the organic layer, the obtained residue was purified by 
column chromatography (CH2Cl2MeOH, 100:0  98:2) yielding 9 (640 mg, 48%) as a white 
foam and recuperated starting material 8 (355 mg, 37 %). 1H-NMR (300 MHz, DMSO-d6):  1.73 
(3 H, s, 5-CH3), 1.90 (3H, s, OCOCH3), 2.11 (3H, s, OCOCH3), 4.28 (1H, d, J = 12.6 Hz, H-5'A), 
4.35 (1H, d, J = 12.1 Hz, H-5'B), 5.16 (1H, dd, J = 3.3 and 9.9 Hz, H-2'), 5.34 and 5.36 (2H, 2s, 
methylene), 5.78 (1H, d, J = 3.0 Hz, H-3'), 5.93 (1H, d, J = 9.9 Hz, H-1'), 7.67 (1H, s, H-6); 
HRMS (ESI-MS) for C15H18N2O7 M+Na+: found, 361.1011; calcd, 361.1011; UV 265 (9839). 
1-[4-Deoxy-4-methylene--D-erythro-pentopyranosyl]thymine (10) 
A solution of 9 (30 mg, 0.089 mmol) in methanolic ammonia solution 7 N (5 mL) was stirred 2h 
at room temperature and was evaporated under reduced pressure. The resulting residue was 
purified by column chromatography (CH2Cl2MeOH, 90:10) yielding 10 (20 mg, 89%) as a 
white foam. 1H-NMR (300 MHz, DMSO-d6):  1.75 (3 H, d, J  = 1.2 Hz, 5-CH3), 3.68 (1H, m, 
H-2'), 4.02 and 4.28 (3H, d and m, H-3' and H-5'), 5.00 (1H, br s, methylene), 5.07 (1H, d, J = 1.8 
Hz, methylene), 5.74 (1H, d, J = 9.3 Hz, H-1'), 7.52 (1H, q, H-6); 13C NMR (75 MHz, DMSO-
d6):  12.5 (5-CH3), 67.4, 69.9 and 73.0 (C-2', C-3' and C-5'), 80.3 (C-1'), 110.3 (C-5), 114.5 (C-
6'), 137.5 (C-6), 144.0 (C-4'), 151.7 (C-2), 164.6 (C-4); HRMS (ESI-MS) for C11H14N2O5Na 
M+Na+: found, 277.0812; calcd, 277.0800; UV 265 (10830).  
1-[4-Deoxy-2,3-O-isopropylidene-4-methylene--D-erythro-pentopyranosyl]thymine (11) 
To a stirred suspension of 10 (129 mg, 0.51 mmol) in anhydrous acetone (3 mL) and 2,2-
dimethoxypropane (0.31 mL, 2.52 mmol) was added p-toluenesulphonic acid monohydrate (97 
mg, 0.51 mmol). After 4 h the resulting solution was poured slowly into stirred aqueous 0.5 M 
NaHCO3 (2 mL). The solution was concentrated in vacuo to ca 1.5 mL, diluted with water and 
extracted with CH2Cl2. The combined organic layers were dried, evaporated under reduced 
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pressure and quickly sent over a silica gel column (CH2Cl2MeOH, 97:3) yielding 11 (124 mg, 
83%) as a white foam. HRMS (ESI-MS) for C14H18 N2O5Na M + Na+: found, 317.1109; calcd, 
317.1113. 
1-[4-Deoxy-4-(hydroxymethyl)-2,3-O-isopropylidene--D-ribopyranosyl]thymine (12) 
To an ice cooled solution of 11 (102 mg, 0.40 mmol) in anhydrous THF (1 mL), under nitrogen, 
was added dropwise 9-BBN-H (2.0 mL of a 0.5 M solution in THF, 1.0 mmol). The mixture was 
slowly warmed to room temperature and stirred for 24h. The reaction mixture was  cooled to 0°C, 
treated sequentially with EtOH (1.6 mL),  a 2 N solution of NaOH (0.78 mL, 1.56 mmol) and 
30% aqueous H2O2 solution (0.78 mL, 6.8 mmol). The resulting mixture was stirred 24 h and 
then poured into a mixture of EtOAc (10mL) and water (10mL). The layers were separated and 
the aqueous layer was extracted with EtOAc (3 times). The combined organic layers were dried 
over MgSO4 and evaporated under reduced pressure. The obtained residue was purified by 
column chromatography (CH2Cl2MeOH, 95:598:2) yielding pure 12 (77 mg, 62%) as a white 
foam. 1H-NMR (300 MHz, DMSO-d6):  1.09 (3 H, s, C(CH3)2), 1.26 (3H, s, C(CH3)2), 1.76 (3H, 
s, 5-CH3), 2.23 (1H, m, H-4'), 3.20 (1H, dd, J = 11.2 and 5.4 Hz, H-6'A), 3.37 (1H, dd, J = 8.31 
and 10.8 Hz, H-5'A), 3.43 (1H, t, J = 11.72, H-6'B), 3.53 (1H, dd, J = 10.8 and 6.35 Hz, H-5'B), 
4.33 (1H, m, H-2'), 4.42 (1H, m, H-3'), 4.71 (1H, t, 6'-OH), 5.41 (1H, d, J = 9.0 Hz, H-1'), 7.63 
(1H, q, J = 0.9 Hz, 6-H); 13C NMR (75 MHz, DMSO-d6):  12.5 (5-CH3), 28.4 and 27.0 
(C(CH3)2), under DMSO signal (C-4'), 59.5 (C-6'), 66.6 (C-5'), 72.7 and 74.1 (C-2' and C-3'), 
82.0 (C-1'), 110.1 (C-5), 110.8 C(CH3)2), 137.3 (C-6), 151.4 (C-2), 164.2 (C-4); HRMS (ESI-
MS) for C14H20N2O6Na M+H+: found, 335.1232; calcd, 335.1219; UV 265 (10640). 
1-[4-Deoxy-4-(hydroxymethyl)--D-ribopyranosyl]thymine (13) 
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Compound 12 (70 mg, 0.21 mmol) was refluxed for 3 hours in a 1:1 mixture of HOAcH2O (5 
mL). The mixture was evaporated under reduced pressure, co-evaporated with EtOH and the 
resulting residue was purified by column chromatography (CH2Cl2MeOH, 95:5), yielding 13 
(51 mg, 98%) as a white foam. 1H-NMR (300 MHz, DMSO-d6):  1.76 (1H, d, J = 0.9 Hz, 5-
CH3), 1.91 (1H, m, H-4'), under H2O-signal (1H, H-6'A), 3.41 (1H, dd, J = 6.3 and 10.8 Hz, H-
6'B), 3.52 (1H, t, J = 11.7 Hz, H-5'A), 3.63 (1H, dd, J = 3.6 and 9.3 Hz, H-2'), 3.68 (1H, dd, J = 
4.8 and 10.8 Hz, H-5'B), 3.95 (1H, br s, H-3'), 4.49 (1H, br s, 6'-OH), 4.92 (1H, br s, 3'-OH, 5.11 
(1H, br s, 2'-OH), 5.60 (1H, d, J = 9.6 Hz, H-1'), 7.57 (1H, q, J = 1.2 Hz, 6-H); 13C NMR (75 
MHz, DMSO-d6):  12.7 (5-CH3), 43.9 (C-4'), 59.8 (C-6'), 64.9 (C-5'), 68.8 and 69.4 (C-2' and C-
3'), 80.7 (C-1'), 109.9 (C-5), 137.7 (C-6), 151.8 (C-2), 164.5 (C-4); HRMS (ESI-MS) for 
C11H16N2 O6Na M + Na+: found, 295.9010; calcd, 295.0906; UV 265 (10320). 
1-[4-Deoxy-4-(hydroxymethyl)-3,6-O-isopropylidene--D-ribopyranosyl]thymine (14) 
To a stirred suspension of 13 (13 mg, 0.048 mmol) in anhydrous acetone (0.1 mL) and 2,2-
dimethoxypropane (0.03 mL, 0.24 mmol) was added p-toluenesulphonic acid monohydrate (0.15 
mg, 0.8 mol). After 1 h the resulting solution was poured slowly into stirred aqueous 0.5 M 
NaHCO3 (2 mL). The solution was concentrated in vacuo, diluted with water and extracted with 
CH2Cl2. The combined organic layers were dried, evaporated under reduced pressure and purified 
by column chromatography (CH2Cl2MeOH, 98:2  97:3) yielding pure 14. 1H-NMR (300 
MHz, DMSO-d6):  1.33 (3 H, s, C(CH3)2), 1.41 (3H, s, C(CH3)2), 1.76 (4H, m, 5-CH3 and H-4'), 
3.45-4.05 (5H, m, H-5', H-6' and H-2'), 4.38 (1H, m, 1/2 = 6.6 Hz, H-3'), 5.09 (1H, br s, 2-OH), 
5.59 (1H, d, J = 9.9 Hz, H-1'), 7.58 (1H, s, 6-H); 13C NMR (75 MHz, DMSO-d6):  12.6 (5-CH3), 
19.3 and 30.3 (C(CH3)2), 34.0 (C-4'), 60.1 (C-6'), 64.8, 67.4 and 69.3 (C-2', C-3' and C-5'), 80.2 
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(C-1'), 99.2 (C(CH3)2), 110.1 (C-5), 137.4 (C-6), 151.7 (C-2), 164.4 (C-4); HRMS (ESI-MS) for 
C14H20N2O6 M+Na+: found, 335.1207; calcd, 335.1219; UV 265 (10625). 
2,3-O-Isopropylidene-1-O-methyl-4-O-phenoxythiocarbonyl--L-lyxopyranose (17) 
To an ice-cold solution of 16 (2.50 g, 12.2 mmol) and DMAP (3.00 g, 24.5 mmol) in CH3CN 
(100 mL) was gradually added phenyl chlorothionocarbonate (2.3 mL, 16.4 mmol). The mixture 
was stirred at 0 °C for 5 h. The solvent was removed in vacuo, and the residue was dissolved in 
CH2Cl2. The solution was washed with water, dried over anhydrous MgSO4, filtered, and 
evaporated in vacuo. The obtained residue was purified by column chromatography 
(CH2Cl2MeOH, 95:5) to give 17 (3.6 g, 87 %) as a syrup. 1H NMR (300 MHz, CDCl3):  1.39 
(3H, s, C(CH3)2), 1.58 (3H, s, C(CH3)2), 3.46 (3H, s, OCH3), 3.83 (1H, dd, J = 7.5 and 12.0 Hz, 
H-5A), 3.92 (1H, dd, J = 4.2 and 12.1 Hz, H-5B), 4.16 (1H, dd, J = 5.4 and 3.2 Hz, H-2), 4.45 
(1H, m, H-3), 4.71 (1H, d, J = 3.0 Hz, H-1), 5.49 (1H, m, H-4), 7.10-7.44 (5H, m, arom H); 13C 
NMR (75 MHz, CDCl3):  26.5 and 28.1 (C(CH3)2), 56.1 (OCH3), 58.7 (C-5), 74.5 (C-3), 75.4 
(C-2), 78.9 (C-4), 100.3 (C-1), 110.2 (C(CH3)2), 122.1 (arom Co), 126.9 (arom Cp), 129.8 (arom 
Cm), 153.6 (arom Ci), 194.7 (O(CS)O); HRMS (ESI-MS) for C16H20O6S1Na M + Na+: found, 
363.0865; calcd, 363.0878. 
2,3-O-Isopropylidene-1-O-methyl-4-C-(2-phenylethenyl)--L-lyxopyranose (18) 
To a solution of 17 (1.47 g, 4.3 mmol) in benzene (34 mL) was added -tributylstannylstyrene 
(4.02 g, 10.22 mmol). The resulted solution was degassed three times with nitrogen at room 
temperature and 45°C. After 2,2'-azobisisobutyronitrile (AIBN) (230 mg, 1.4 mmol) was added, 
the solution was refluxed for 2h. Another part of AIBN (230 mg, 1.4 mmol) was added after 
cooling the reaction mixture to 40° C. The reaction mixture was then refluxed for 2h. This 
procedure was repeated until the starting material disappeared (6 times). The solvent was 
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evaporated, and the residue was purified by column chromatography (CH2Cl2MeOH, 98:2) to 
give 18 (773 mg, 62 %) as an oil. 1H NMR (300 MHz, CDCl3):  1.26 (3H, s, CCH3), 1.44 (3H, s, 
CCH3), 2.55 (1H, m, H-4), 3.46 (3H, s, OCH3), 3.50 (2H, app d, H-5), 3.92 (1H, dd, J =  2.1 and 
5.1 Hz, H-2), 4.11 (1H, dd, J = 5.1 and 7.2 Hz, H-3), 4.78 (1H, d, J = 2.1 Hz, H-1), 6.15 (1H, dd, 
J = 16.2 and 7.8 Hz, H- styrene), 6.52 (1H, d, J = 16 Hz, H- styrene), 7.11-7.40 (5H, m, arom 
H); 13C NMR (75 MHz, CDCl3):  26.6 (CCH3), 28.5 (CCH3), 42.8 (C-4), 55.7 (OCH3), 61.3 (C-
5), 73.9 (C-3), 76.1 (C-2), 99.9 (C-1), 109.3 (CCH3), 126.5 (arom Co), 127.2 and 127.7 (arom Cp 
and C styryl), 128.7 (arom Cm), 132.8 (C styryl), 137.1 (arom Ci); HRMS (ESI-MS) for 
C17H22O4Na M + Na+: found, 313.1412; calcd, 313.1415. 
4-Deoxy-4-C-hydroxymethyl-2,3-O-isopropylidene-1-O-methyl--L-lyxopyranose (20)  
To a solution of styrene 18 (330 mg, 1.1 mmol) and N-methylmorpholine-N-oxide (NMMO) (200 
mg, 1.7 mmol) in dioxane (20 mL), was added a catalytic amount of osmium tetraoxide 4% in 
H2O (0.3 mL, 0.04 mmol). The flask was covered by aluminium foil, and the reaction mixture 
was stirred at room temperature overnight. A solution of NaIO4 (731 mg, 3.4 mmol) in water (1 
mL) was added to the stirred reaction mixture. It was stirred for 1 h at 0° C and 2h at room 
temperature, followed by addition of EtOAc (20 mL). The mixture was filtered through a celite 
pad and washed with EtOAc. The filtrate was washed three times with 10% aqueous Na2S2O3 
solution until the color of the aqueous phase disappeared. The organic phase was further washed 
with water, dried (MgSO4) and concentrated. The obtained aldehyde was dissolved in EtOHH2O 
(4:1 v/v, 16 mL). NaBH4 (190 mg, 5.0 mmol) was added in portions at 0° C. The resulting 
reaction mixture was stirred at room temperature for 2 h and then treated with ice water. The 
mixture was extracted with EtOAc. The organic phase was washed with water and brine, dried 
(MgSO4) and concentrated. The obtained residue was purified by column chromatography 
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(CH2Cl2MeOH, 9:1) to give 20 (127 mg, 53 % over three steps) as an oil. 1H NMR (300 MHz, 
DMSO-d6):  1.24 (3H, s, CCH3), 1.38 (3H, s, CCH3), 1.78 (1H, m, H-4), 3.28 (3H, s, OCH3), 
3.30-3.55 (4H, m, H-5 and H-6), 3.79 (1H, dd, J = 3.0 and 5.4 Hz, H-2), 4.03 (1H, dd, J = 5.1 and 
6.6 Hz, H-3), 4.60 (1H, d, J = 3.0 Hz, H-1), 4.66 (1H, t, J = 5.7 Hz, 6-OH); 13C NMR (75 MHz, 
DMSO-d6):  26.9 (CCH3), 22.8 (CCH3), under DMSO signal (C-4), 55.5 (OCH3), 59.9 and 60.1 
(C-5 and C-6), 72.5 (C-3), 73.8 (C-2), 100.5 (C-1), 108.6 (CCH3); HRMS (ESI-MS) for 
C10H18O5Na M + Na+: found, 241.1050; calcd, 241.1052.  
2,3,6-Tri-O-acetyl-4-deoxy-4-C-hydroxymethyl-1-O-methyl--L-lyxopyranose (21)12 
A solution of 20 (72 mg, 0.3 mmol) in trifluoroacetic acidH2O (9:1 v/v, 1 mL) was stirred for 5 
minutes. The solution was neutralized with Dowex 1x2 (OH-). The resin was removed by 
filtration and washed with MeOHH2O (3:1). The filtrate was evaporated under diminished 
pressure and purified by column chromatography (CH2Cl2MeOH, 90:10), yielding 4-deoxy-4-
C-hydroxymethyl-1-O-methyl--L-lyxopyranose 12 (45 mg, 77 %) as a glassy solid. 1H NMR 
(300 MHz, DMSO-d6):  1.91 (1H, m, H-4), 3.20 (3H, s, OCH3), 3.30-3.61 (6H, m, H-6, H-2, H-
3 and H-5), 4.35 (2H, t, 6- and 3-OH), 4.45 (1H, d, J = 4.5 Hz, H-1), 4.47 (1H, app d, J = 2.1 Hz, 
2-OH); 13C NMR (75 MHz, DMSO-d6):  under DMSO signal (C-4), 54.9 (OCH3), 60.1, 61.8, 
66.7 and 69.4 (C-6, C-2, C-3 and C-5), 102.5 (C-1); HRMS (ESI-MS) for C7H14O5Na M + Na+: 
found, 201.0750; calcd, 201.0739. The above mentionned glassy solid (40 mg, 0.2 mmol) was 
dissolved in pyridine (2.5 mL) and acetic anhydride (2.5 mL) was added. The solution was stirred 
at room temperature for 3 h. The solvent was removed under vacuum and the resulting residue 
was purified by column chromatography (CH2Cl2MeOH, 99:1) to yield 21 (60 mg, 89 %) as a 
foam. 1H NMR (300 MHz, CD3OD):  1.97, 2.02 and 2.10 (OCOCH3), 2.47 (1H, m, H-4), 3.38 
(3H, s, OMe), 3.70 (1H, t, J = 11.4 Hz, H-5A), 3.77 (1H, dd, J = 11.4 and 5.4 Hz, H-5B), 4.01 
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(1H, dd, J = 11.4 and 2.7 Hz, H-6A), 4.11 (1H, dd, J = 6.0 and 11.7 Hz, H-6B), 4.65 (1H, d, J = 
5.1 Hz, H-1), 5.09 (1H, dd, J = 5.1 and 3.0 Hz, H-2), 5.13 (1H, dd, J = 3.0 and 11.0 Hz, H-3); 13C 
NMR (75 MHz, CD3OD):  19.3, 19.4 and 19.5 (OCOCH3), 35.7 (C-4), 54.0 (OCH3), 60.3 (C-5), 
61.0 (C-6), 67.3 (C-3), 68.1 (C-2), 99.3 (C-1), 170.6, 170.9 and 170.2 (OCOCH3); HRMS (ESI-
MS) for C13H20O8Na M + Na+: found, 327.1058; calcd, 327.1056.  
1-2,3,6-O-Tri-acetyl-4-deoxy-4-C-hydroxymethyl--L-lyxopyranosylthymine (22)12 
Thymine (615 mg, 4.9 mmol) was suspended in hexamethyldisilazane (55 mL, 260 mmol), 
containing trimethylsilylchloride (0.48 mL, 3.8 mmol) and pyridine (4 mL). The mixture was 
heated to 125° C and stirred overnight. The reaction mixture was evaporated and co-evaporated 
with toluene. The resulting residue and 21 (744 mg, 2.44 mmol) were dissolved in CH3CN (17 
mL), SnCl2 (anhydrous, 1.23 g, 6.5 mmol) was added and the mixture was refluxed under 
nitrogen during 39 h. After cooling it was poured in 10 % Na2CO3 and extracted with CH2Cl2. 
After drying  and evaporation of the organic layer, the obtained residue was purified by column 
chromatography (CH2Cl2MeOH 99:1  97:3) yielding pure 22 (367 mg, 38%) as a white foam 
and residual starting product 21 (315 mg, 42 %). 1H NMR (300 MHz, DMSO-d6):  1.75 (3H, s, 
5-CH3), 1.88, 2.04 and 2.11 (OCOCH3), 2.18 (1H, m, H-4'), 3.86 (1H, d, J = 12.3 Hz, H-5'A), 
3.97 (1H, d, J = 12.3 Hz, H-5'B), 4.36 (2H, m, H-6'A and H6'B), 5.30 (1H, dd, J = 2.7 Hz and 9.9 
Hz, H-2'), 5.45 (1H, br s, H-3'), 5.80 (1H, d, J = 9.9 Hz, H-1'), 7.82 (1H, s, 6-H), 11.40 (1H, s, 
NH); 13C NMR (75 MHz, DMSO-d6):  12.5 (5-CH3), 21.0, 21.3 and 21.5 (OCOCH3), 55.6 (C-
4'), 62.5 and 64.9 (C-5' and C-6'), 66.2 and 68.4 (C-2' and C-3'), 79.2 (C-1'), 110.7 (C-5), 137.1 
(C-6), 151.4 (C-2), 164.2 (C-4), 169.8, 170.3 and 170.9 (OCOCH3); HRMS (ESI-MS) for 
C17H22N2O9Na M + Na+: found, 421.1253; calcd, 421.1223; UV 265 (8800).  
1-4-Deoxy-4-C-hydroxymethyl--L-lyxopyranosylthymine (5)12 
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Compound 22 (410 mg, 1.03 mmol) was treated with a 7N methanolic ammonia solution (30 mL) 
at room temperature for 7 h. Evaporation yielded a residue which was purified by column 
chromatography (CH2Cl2MeOH, 90:10) to afford 5 (218 mg, 78%) as a white foam. 1H NMR 
(300 MHz, DMSO-d6):  1.77 (4H, br s, 5-CH3 and H-4'), 3.50 (1H, m, H-6'A), 3.59 (1H, m, H-
6'B), 3.66 (2H, m, H-5'A and H-2'), 3.83 (1H, dd, J = 2.4 and 11.1 Hz, H-5'B), 3.97 (1H, br s, H-
3'), 4.65 (1H, t, J = 5.1 Hz, 6'-OH),  4.97 (2H, br s, 2'-OH and 3'-OH), 5.59 (1H, d, J = 9.6 Hz, H-
1'), 7.56 (1H, s, 6-H), 11.25 (1H, s, NH); 13C NMR (75 MHz, DMSO-d6):  12.6 (5-CH3), 46.0 
(C-4'), 60.0 (C-6'), 63.9 (C-2') and 66.2 (C-5'), 68.8 (C-3'), 81.2 (C-1'), 109.9 (C-5), 137.7 (C-6), 
151.7 (C-2), 164.4 (C-4); HRMS (ESI-MS) for C11H16N2O6Na M + Na+: found, 295.0902; 
calcd, 295.0906; Anal. (C11H16N2O6) C, H, N; UV 265 (10120). 
1-4-Deoxy-4-C-hydroxymethyl-3,6-O-(1,1,3,3,-tetraisopropyldisiloxan-1,3-diyl)--L-
lyxopyranosylthymine (23)  
Compound 5 (46 mg, 0.17 mmol) and imidazole (60 mg, 0.88 mmol) were dissolved in DMF (1 
mL) at 0°C. 1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane (58 L, 0.19 mmol) was added 
dropwise. The mixture was stirred 3h at room temperature and overnight at 30°C. Water was 
added and the mixture was extracted with CH2Cl2. The organic layer was dried over MgSO4 and 
evaporated under reduced pressure. The obtained residue was purified by column 
chromatography (CH2Cl2MeOH, 99:1) to afford 23 (78 mg, 89%) as a white foam. 1H NMR 
(300 MHz, DMSO-d6):  0.95 (28H, m, CH(CH3)2), 1.75 (3H, s, 5-CH3), 2.22 (1H, m, H-4'), 3.55 
(1H, d, J = 11.1 Hz, H-6'A), 3.75 (1H, t, J = 11.4 Hz, H-5'A), 3.87 (1H, dd, J = 5.7 and 11.4 Hz, 
H-5'B), 3.92 (1H, dd, J = 2.1 and 11.1 Hz, H-6'B), 3.99 (1H, dd, J = 2.7 and 10.2 Hz, H-3'), 4.49 
(1H, br, H-2'), 5.30 (1H, d, J = 5.1 Hz, 2'-OH), 5.36 (1H, d, J = 2.7 Hz, H-1'), 7.41 (1H, s, 6-H), 
11.31 (1H, s, NH); 13C NMR (75 MHz, DMSO-d6):  12.6, 12.7, 12.8, 13.4, 13.5 (CH(CH3)2 and 
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5-CH3), 17.1, 17.8, 17.8, 17.9, 17.9 (CH(CH3)2), 38.8 (C-4'), 59.4 (C-6'), 65.2 (C-5'), 66.5 (C-3'), 
68.2 (C-2'), 88.5 (C-1'), 109.8 (C-5), 137.6 (C-6), 151.3 (C-2), 164.4 (C-4); HRMS (ESI-MS) for 
C23H43N2O7Si2 M + H+: found, 515.2619; calcd, 515.2608; UV 265 (10090).  
1-4-Deoxy-4-C-hydroxymethyl-3,6-O-(1,1,3,3,-tetraisopropyldisiloxan-1,3-diyl)-2-O-
phenoxythiocarbonyl--L-lyxopyranosylthymine (24) 
Compound 23 (126 mg, 0.24 mmol) was dissolved in anhydrous CH3CN (4 mL). DMAP (58 mg, 
0.48 mmol) was added at 0°C. The mixture was stirred 15 min at 0°C, then 
phenylchlorothionocarbonate (46 L, 0.33 mmol) was added dropwise and the resulting solution 
was stirred overnight at room temperature. After adding 7% NaHCO3 solution (7mL), the mixture 
was evaporated to dryness, the obtained residue was dissolved in EtOAc, washed with water, 
dried over MgSO4, evaporated under reduced pressure and purified by column chromatography 
(CH2Cl2MeOH, 99.5:0.5) to afford 24 (140 mg, 89%) as a white foam. 1H NMR (300 MHz, 
CDCl3):  1.03 (28H, m, CH(CH3)2), 1.94 (3H, s, 5-CH3), 2.25 (1H, m, H-4'), 3.60 (1H, d, J = 
11.7 Hz, H-6'A), 3.82-3.99 (2H, m, H-5'A and H-5'B), 4.10 (1H, dd, J = 11.7 and 2.4 Hz, H-6'B), 
4.52 (1H, dd, J = 2.8 and 11.1 Hz, H-3'), 5.61 (1H, d, J = 2.6 Hz, H-1'), 6.58 (1H, d, J = 2.7 Hz, 
H-2'), 7.09-7.44 (5H, m, arom H), 8.06 (1H, s, 6-H); 13C NMR (75 MHz, CDCl3):  12.6 (5-
CH3), 12.8, 13.0, 13.5, 13.7 (CH(CH3)2), 17.4, 17.5, 17.6, 17.7, 17.7 (CH(CH3)2), 39.7 (C-4'), 
58.7 (C-6'), 65.0 and 65.0 (C-3' and C-5'), 80.8 (C-2'), 85.8 (C-1'), 112.0 (C-5), 122.0 (arom Co), 
126.9 (arom Cp), 129.8 (arom Cm), 136.7 (C-6), 150.0 (arom Ci), 153.6 (C-2), 163.4 (C-4), 194.8 
(OC(S)O); HRMS (ESI-MS) for C30H46N2O8SSi2Na M + Na+: found, 673.2409; calcd, 
673.2411; UV 265 (10000).  
1-2,4-Dideoxy-4-C-hydroxymethyl-3,6-O-(1,1,3,3,-tetraisopropyldisiloxan-1,3-diyl)--L-
lyxopyranosylthymine (25) 
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Compound 24 (134 mg, 0.20 mmol) was co-evaporated three times with anhydrous toluene, 
dissolved in toluene (32 mL) and degassed with nitrogen for 30 minutes. In a second flask, AIBN 
(17 mg, 0.10 mmol) and Bu3SnH (166 L, 0.62 mmol) in toluene (2 mL) were degassed with 
nitrogen for 30 minutes. The first flask was heated to 80°C, the second solution was added 
dropwise via a syringe. The mixture was heated to 90°C for 2h. After cooling to room 
temperature, the mixture was evaporated, and the residue was purified by column 
chromatography (CH2Cl2MeOH, 99.5:0.5) to afford 25 (81 mg, 79%) as a white foam. 1H NMR 
(300 MHz, CDCl3):  1.05 (28H, m, CH(CH3)2), 1.79 (1H, m, H-4'), 1.90 (3H, s, 5-CH3), 2.18 
(1H, m, H-2'A), 2.54 (1H, dd, J = 3.3 and 14.1 Hz, H-2'B), 3.57 (1H, d, J = 11.7 Hz, H-6'A), 3.72 
(1H, t, J = 11.7 Hz, H-5'A), 3.86 (1H, dd, J = 4.8 and 11.7 Hz, H-5'B), 4.14 (1H, dd, J = 2.7 and 
12.0 Hz, H-6'B), 4.26 (1H, m, H-3'), 5.93 (1H, d, J = 4.8 Hz, H-1'), 8.04 (1H, s, 6-H); 13C NMR 
(75 MHz, CDCl3):  12.7 (5-CH3), 12.8, 13.5, 13.8 (CH(CH3)2), 17.4, 17.4, 17.5, 17.5, 17.6, 17.6 
(CH(CH3)2, 36.4 (C-2'), 45.7 (C-4'), 59.0 (C-6'), 64.8 and 63.3 (C-3' and C-5'), 82.3 (C-1'), 110.5 
(C-5), 136.6 (C-6), 150.5 (C-2), 163.5 (C-4); HRMS (ESI-MS) for C23H43N2O6Si2 M + H+: 
found, 499.2571; calcd, 499.2659; UV 265 (9900).  
1-2,4-Dideoxy-4-C-hydroxymethyl--L-lyxopyranosylthymine (4) 
Compound 25 (76 mg, 0.15 mmol) was dissolved in THF (8 mL) and Bu4NF (1M in THF, 0.76 
mL, 0.76 mmol) was added. The mixture was stirred for 1h at room temperature, evaporated to 
dryness and purified by column chromatography (CH2Cl2MeOH, 93:7) to afford 4 (38 mg, 
97%) as a white foam. 1H NMR (300 MHz, DMSO-d6):  1.51 (2H, m, H-2'A and H-4'), 1.76 
(3H, s, 5-CH3), 1.96 (1H, app t, J = 11.4 Hz, H-2'B), 3.50 (1H, m, J = 8.4 and 10.2 Hz, H-6'A), 
3.60 (1H, m, J = 7.2 and 10.2 Hz, H-6'B), 3.77 (1H, d, J = 11.4 Hz, H-5'A), 3.92 (1H, dd, J = 2.1 
and 11.4 Hz, H-5'B), 4.02 (1H, m, H-3'), 4.58 (1H, t, J = 5.1 Hz, 6'-OH), 4.98 (1H, d, J = 2.7 Hz, 
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3'-OH), 5.82 (1H, d, J = 11.4 Hz, H-1'), 7.57 (1H, s, 6-H), 11.25 (1H, s, NH); 13C NMR (75 MHz, 
DMSO-d6):  12.6 (5-CH3), 33.8 (C-2'), 43.4 (C-4'), 60.5 (C-6'), 64.7 (C-5'), 64.8 (C-3'), 78.1 (C-
1'), 110.1 (C-5), 137.3 (C-6), 150.9 (C-2), 164.4 (C-4); HRMS (ESI-MS) for C11H16N2O5Na M + 
Na+: found, 279.0952; calcd, 279.0957; Anal. (C11H16N2O5) C, H, N; UV 265 (10590). 
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